Millendo Therapeutics Inc (MLND)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 46.09M | 37.33M | 30.74M | 23.99M | 51.6M | 44.38M | 42.17M | 33.84M |
流動資産合計 | 32.95M | 24.67M | 18.54M | 12.29M | 40.36M | 33.5M | 31.55M | 23.55M |
現金および同等物 | 31.23M | 22.93M | 17.6M | 11.12M | 39.23M | 32.33M | 31.12M | 22.12M |
非流動資産合計 | 14.2M | 13.66M | 13.21M | 12.62M | 12.08M | 11.8M | 11.64M | 11.22M |
負債合計 | 27.98M | 26.36M | 25.73M | 25.18M | 24.84M | 23.75M | 25.23M | 22.38M |
流動負債合計 | 7.28M | 7.51M | 8.64M | 7.42M | 9.41M | 10.69M | 14.56M | 13.97M |
非流動負債合計 | 31.07M | 27.79M | 24.58M | 26.13M | 21.69M | 17.2M | 12.68M | 8.41M |
普通株 | 11k | 11k | 13k | 14k | 22k | 22k | 24k | 27k |
留保所得 | -135.77M | -143.41M | -150.99M | -157.78M | -165.26M | -173.17M | -182.74M | -193.29M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 122.54M | 72.85M | 84.07M | 74.97M | 43.41M | 73.24M | 46.09M | 51.6M |
流動資産合計 | 116.44M | 68.78M | 83.42M | 71.13M | 40.9M | 68.96M | 32.95M | 40.36M |
現金および同等物 | 43.93M | 15.7M | 73.29M | 62.48M | 38.17M | 51.83M | 31.23M | 39.23M |
非流動資産合計 | 108.22M | 64.3M | 73.12M | 59.87M | 33.73M | 36.12M | 18.11M | 26.77M |
負債合計 | 14.33M | 8.56M | 10.95M | 15.1M | 9.68M | 37.12M | 27.98M | 24.84M |
流動負債合計 | 13.21M | 7.8M | 9.82M | 12.52M | 7.99M | 20.03M | 7.28M | 9.41M |
非流動負債合計 | 1.12M | 751k | 1.52M | 2.75M | 1.76M | 32.16M | 31.07M | 21.69M |
総資本 | 108.22M | 64.3M | 73.12M | 59.87M | 33.73M | 36.12M | 18.11M | 26.77M |
普通株 | 36k | 36k | 13k | 18k | 19k | 7k | 11k | 22k |
留保所得 | -250.18M | -301.48M | -164.09M | -208.65M | -245.06M | -100.06M | -135.77M | -165.26M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約